Large Enterprises – Page 32 – GSS EU Science Funding Gateway

admin

2 years ago

Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients

admin

2 years ago

Setting up a European Electronic Health Record Exchange Format (EEHRxF) Ecosystem

admin

2 years ago

New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

admin

2 years ago

Prevention of obesity throughout the life course

admin

2 years ago

Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression

admin

2 years ago

New pricing and payment models for cost-effective and affordable health innovations

admin

2 years ago

Relationship between infections and non-communicable diseases

admin

2 years ago

Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)

admin

2 years ago

European Partnership on Rare Diseases

admin

2 years ago

EU Funding Programmes

Dissemination & Valorisation

Innovation & Strategy Advisory

Specialised COST Action Deliverables

EU Funding Programmes

Dissemination & Valorisation

Innovation & Strategy Advisory

EU Funding Programmes

Dissemination & Valorisation

Innovation & Strategy Advisory

Specialised COST Action Deliverables

EU Funding Programmes

Dissemination & Valorisation

Innovation & Strategy Advisory

Looking for collaboration?

Archive

admin

Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients

admin

Setting up a European Electronic Health Record Exchange Format (EEHRxF) Ecosystem

admin

New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment

admin

Prevention of obesity throughout the life course

admin

Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression

admin

New pricing and payment models for cost-effective and affordable health innovations

admin

Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)

admin

European Partnership on Rare Diseases

admin

Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases – GACD)

Case studies

About Us

Company